Cardiovascular Risk of Proton Pump Inhibitors. Review uri icon

Overview

abstract

  • Proton pump inhibitors (PPIs) are effective agents for the treatment of gastroesophageal reflux (GERD). However, these drugs have not been approved for long-term use. Now sold over the counter, these agents are being used chronically for GERD without medical supervision. The long-term use of PPIs may have significant adverse effects, in part mediated by their effect of accelerating vascular aging. Physicians should assist patients in tapering off their use of PPIs and replacing them with lifestyle modifications and/or other agents that have better long-term safety profiles.

publication date

  • January 1, 2019

Research

keywords

  • Cardiovascular Diseases
  • Gastroesophageal Reflux
  • Proton Pump Inhibitors

Identity

PubMed Central ID

  • PMC6822659

Scopus Document Identifier

  • 85074547768

Digital Object Identifier (DOI)

  • 10.14797/mdcj-15-3-214

PubMed ID

  • 31687101

Additional Document Info

volume

  • 15

issue

  • 3